Method for efficiently inducing human umbilical cord mesenchymal stem cells to be differentiated into hepatocytes and application
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- NO 1 THE PEOPLES HOSPITAL HUAIAN CITY
- Publication Date
- 2021-12-14
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the technical field of stem cells and regenerative medicine, and mainly relates to a method for efficiently differentiating human umbilical cord mesenchymal stem cell lines overexpressing LINC5657 into hepatocytes in a culture medium containing inducers HGF, EGF, bFGF and OSM. Background technique
[0002] Various end-stage liver diseases often lead to liver failure, causing great harm to human health, and are one of the main causes of death worldwide. At present, liver cell transplantation is considered to be one of the important methods for the treatment of acute and chronic liver failure, but the lack of enough donors limits its wide application in clinical practice.
[0003] With the rapid development of stem cell technology in recent years, adult stem cells provide an unlimited source of primary cells for in vitro research. Among adult stem cells, mesenchymal stem cells have the most application prospects, which have the ...